The Lancet Regional Health: Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination Summary Background Two new products for preventing Respiratory Syncytial Virus (RSV) in young…